Stock Overview

Fresenius Medical Care Corporation (FMS)

NYSE · Healthcare · Medical Care Facilities

Fresenius Medical Care Corporation is a Healthcare company with a market capitalization of $12.48B, a trailing P/E ratio of 12.5, and a dividend yield of 3.75%.

Market Cap
$12.48B
P/E (TTM)
12.5
Forward P/E
9.9
Price/Sales
0.7
Price/Book
0.8
EV/EBITDA
6.0
Dividend Yield
3.75%
Beta
0.81
EPS (TTM)
$1.86
Profit Margin
4.9%
ROE
7.8%
52W High
$27.75
52W Low
$19.24

5-Year Price History

Latest Annual Financials · FY ending December 31, 2025 · in EUR

Revenue
19.63B EUR
Gross Profit
5.03B EUR
Operating Income
1.83B EUR
Net Income
978.37M EUR
Free Cash Flow
1.70B EUR
Total Debt
7.89B EUR
Cash & Equivalents
1.60B EUR
Shareholder Equity
14.28B EUR

Recent Quarterly Earnings (EPS)

QuarterReportedActual EPSEstimateSurprise
Q1 2026May 5, 2026$0.46$0.53-13.6%
Q4 2025February 24, 2026$0.72$0.55+30.9%
Q3 2025November 4, 2025$0.55$0.50+10.0%
Q2 2025August 5, 2025$0.46$0.47-2.1%
Q1 2025May 6, 2025$0.42$0.38+10.5%
Q4 2024February 25, 2025$0.46$0.40+13.6%

Other Medical Care Facilities Stocks

Frequently Asked Questions

What is Fresenius Medical Care Corporation's market cap?

As of June 29, 2026, Fresenius Medical Care Corporation (FMS) has a market capitalization of $12.48B.

What is Fresenius Medical Care Corporation's P/E ratio?

Fresenius Medical Care Corporation trades at a trailing price-to-earnings (P/E) ratio of 12.5. Its forward P/E is 9.9.

Does Fresenius Medical Care Corporation pay a dividend?

Yes — Fresenius Medical Care Corporation pays a dividend yielding 3.75%, an annual payout of $1.49 per share.

What sector is FMS in?

Fresenius Medical Care Corporation is in the Healthcare sector, specifically the Medical Care Facilities industry.

What was Fresenius Medical Care Corporation's revenue?

In its latest reported fiscal year (ending December 31, 2025), Fresenius Medical Care Corporation reported revenue of 19.63B EUR and net income of 978.37M EUR.

Ask your own questions about FMS

Try mrmarket.ai free

Data as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.